1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Bioanalytical Testing Services Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Bioanalytical Testing Services Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Bioanalytical Testing Services Market Regional Analysis
6.2 Europe Bioanalytical Testing Services Market Revenue 2020-2030 (US$ Million)
6.3 Europe Bioanalytical Testing Services Market Forecast Analysis
7. Europe Bioanalytical Testing Services Market Analysis – by Services
7.1 Pharmacokinetics
- 7.1.1 Overview
- 7.1.2 Pharmacokinetics: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Biomarkers
- 7.2.1 Overview
- 7.2.2 Biomarkers: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Immunogenicity
- 7.3.1 Overview
- 7.3.2 Immunogenicity: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Virology Testing
- 7.4.1 Overview
- 7.4.2 Virology Testing: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Cell-based assays
- 7.5.1 Overview
- 7.5.2 Cell-based assays: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Bioanalytical Testing Services Market Analysis – by Disease Indication
8.1 Cardiovascular
- 8.1.1 Overview
- 8.1.2 Cardiovascular: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Neurological Disorders
- 8.2.1 Overview
- 8.2.2 Neurological Disorders: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Metabolic Disorders
- 8.3.1 Overview
- 8.3.2 Metabolic Disorders: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Autoimmune Disorders
- 8.4.1 Overview
- 8.4.2 Autoimmune Disorders: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Respiratory Diseases
- 8.5.1 Overview
- 8.5.2 Respiratory Diseases: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.6 Oncology
- 8.6.1 Overview
- 8.6.2 Oncology: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.7 Sexual Health
- 8.7.1 Overview
- 8.7.2 Sexual Health: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.8 Bone Disease
- 8.8.1 Overview
- 8.8.2 Bone Disease: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Bioanalytical Testing Services Market Analysis – by End User
9.1 Pharmaceutical and Biopharmaceutical Companies
- 9.1.1 Overview
- 9.1.2 Pharmaceutical and Biopharmaceutical Companies: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Contract Research Organization
- 9.2.1 Overview
- 9.2.2 Contract Research Organization: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Contract Development And Manufacturing Organization
- 9.3.1 Overview
- 9.3.2 Contract Development And Manufacturing Organization: Europe Bioanalytical Testing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Bioanalytical Testing Services Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Bioanalytical Testing Services Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 Europe Bioanalytical Testing Services Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 UK: Europe Bioanalytical Testing Services Market Breakdown, by Services
- 10.2.1.1.2 UK: Europe Bioanalytical Testing Services Market Breakdown, by Disease Indication
- 10.2.1.1.3 UK: Europe Bioanalytical Testing Services Market Breakdown, by End User
- 10.2.1.2 Germany:
Europe Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Germany: Europe Bioanalytical Testing Services Market Breakdown, by Services
- 10.2.1.2.2 Germany: Europe Bioanalytical Testing Services Market Breakdown, by Disease Indication
- 10.2.1.2.3 Germany: Europe Bioanalytical Testing Services Market Breakdown, by End User
- 10.2.1.3 France:
Europe Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 France: Europe Bioanalytical Testing Services Market Breakdown, by Services
- 10.2.1.3.2 France: Europe Bioanalytical Testing Services Market Breakdown, by Disease Indication
- 10.2.1.3.3 France: Europe Bioanalytical Testing Services Market Breakdown, by End User
- 10.2.1.4 Russia:
Europe Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Russia: Europe Bioanalytical Testing Services Market Breakdown, by Services
- 10.2.1.4.2 Russia: Europe Bioanalytical Testing Services Market Breakdown, by Disease Indication
- 10.2.1.4.3 Russia: Europe Bioanalytical Testing Services Market Breakdown, by End User
- 10.2.1.5 Italy:
Europe Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.5.1 Italy: Europe Bioanalytical Testing Services Market Breakdown, by Services
- 10.2.1.5.2 Italy: Europe Bioanalytical Testing Services Market Breakdown, by Disease Indication
- 10.2.1.5.3 Italy: Europe Bioanalytical Testing Services Market Breakdown, by End User
- 10.2.1.6 Rest of Europe:
Europe Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Bioanalytical Testing Services Market Breakdown, by Services
- 10.2.1.6.2 Rest of Europe: Europe Bioanalytical Testing Services Market Breakdown, by Disease Indication
- 10.2.1.6.3 Rest of Europe: Europe Bioanalytical Testing Services Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 SGS SA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Pharmaron Beijing Co Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Element Materials Technology Group Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Charles River Laboratories International Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Eurofins Scientific SE
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Labcorp Drug Development Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Syneos Health Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 KCAS Bioanalytical and Biomarker Services LLC
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 ICON Plc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Intertek Group Plc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations